JP2002518346A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002518346A5 JP2002518346A5 JP2000554400A JP2000554400A JP2002518346A5 JP 2002518346 A5 JP2002518346 A5 JP 2002518346A5 JP 2000554400 A JP2000554400 A JP 2000554400A JP 2000554400 A JP2000554400 A JP 2000554400A JP 2002518346 A5 JP2002518346 A5 JP 2002518346A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- tables
- group
- patient
- cytotoxic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 4
- 230000002163 immunogen Effects 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 108700028369 Alleles Proteins 0.000 description 2
- 230000005867 T cell response Effects 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 108091007433 antigens Proteins 0.000 description 2
- 102000036639 antigens Human genes 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 102000043129 MHC class I family Human genes 0.000 description 1
- 108091054437 MHC class I family Proteins 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9858498A | 1998-06-17 | 1998-06-17 | |
| US09/098,584 | 1998-06-17 | ||
| PCT/US1999/013789 WO1999065522A1 (en) | 1998-06-17 | 1999-06-17 | Hla binding peptides and their uses |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010004446A Division JP2010090167A (ja) | 1998-06-17 | 2010-01-12 | Ｈｌａ結合ペプチドおよびそれらの用途 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002518346A JP2002518346A (ja) | 2002-06-25 |
| JP2002518346A5 true JP2002518346A5 (enExample) | 2006-08-10 |
Family
ID=22269985
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000554400A Pending JP2002518346A (ja) | 1998-06-17 | 1999-06-17 | Ｈｌａ結合ペプチドおよびそれらの用途 |
| JP2010004446A Pending JP2010090167A (ja) | 1998-06-17 | 2010-01-12 | Ｈｌａ結合ペプチドおよびそれらの用途 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010004446A Pending JP2010090167A (ja) | 1998-06-17 | 2010-01-12 | Ｈｌａ結合ペプチドおよびそれらの用途 |
Country Status (8)
| Country | Link |
|---|---|
| EP (2) | EP1089757B1 (enExample) |
| JP (2) | JP2002518346A (enExample) |
| AT (1) | ATE429247T1 (enExample) |
| AU (1) | AU4577899A (enExample) |
| CA (1) | CA2330824A1 (enExample) |
| DE (1) | DE69940774D1 (enExample) |
| ES (1) | ES2326146T3 (enExample) |
| WO (1) | WO1999065522A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9340577B2 (en) | 1992-08-07 | 2016-05-17 | Epimmune Inc. | HLA binding motifs and peptides and their uses |
| DE19925199A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
| DE19925235A1 (de) | 1999-06-01 | 2000-12-07 | Medigene Ag | Zytotoxische T-Zellepitope des Papillomavirus L1-Proteins und ihre Verwendung in Diagnostik und Therapie |
| GB9923309D0 (en) * | 1999-10-01 | 1999-12-08 | Glaxo Group Ltd | Assay |
| EP1237564A4 (en) * | 1999-12-10 | 2005-05-04 | Epimmune Inc | TRIGGERING OF CELLULAR IMMUNE RESPONSES AGAINST P53 USING NUCLEIC ACID AND PEPTIDE COMPOSITIONS |
| US7462354B2 (en) | 1999-12-28 | 2008-12-09 | Pharmexa Inc. | Method and system for optimizing minigenes and peptides encoded thereby |
| EP1766393A4 (en) * | 2004-05-07 | 2008-06-18 | Beckman Coulter Inc | MHC-BRIDGE SYSTEM FOR DETECTION OF THE CTL-MEDIATED LYSE OF ANTIGEN-PRESENTING CELLS |
| EP2391635B1 (en) | 2009-01-28 | 2017-04-26 | Epimmune Inc. | Pan-dr binding polypeptides and uses thereof |
| CA2919835A1 (en) | 2013-07-31 | 2015-02-05 | Board Of Trustees Of The University Of Arkansas | Compositions for and methods of treating and preventing cancer targeting tumor associated carbohydrate antigens |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235871A (en) | 1978-02-24 | 1980-11-25 | Papahadjopoulos Demetrios P | Method of encapsulating biologically active materials in lipid vesicles |
| US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
| US4501728A (en) | 1983-01-06 | 1985-02-26 | Technology Unlimited, Inc. | Masking of liposomes from RES recognition |
| US5019369A (en) | 1984-10-22 | 1991-05-28 | Vestar, Inc. | Method of targeting tumors in humans |
| US4690915A (en) | 1985-08-08 | 1987-09-01 | The United States Of America As Represented By The Department Of Health And Human Services | Adoptive immunotherapy as a treatment modality in humans |
| US4844893A (en) | 1986-10-07 | 1989-07-04 | Scripps Clinic And Research Foundation | EX vivo effector cell activation for target cell killing |
| US4837028A (en) | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
| DE69031305T2 (de) | 1989-11-03 | 1998-03-26 | Univ Vanderbilt | Verfahren zur in vivo-verabreichung von funktionsfähigen fremden genen |
| US5279833A (en) | 1990-04-04 | 1994-01-18 | Yale University | Liposomal transfection of nucleic acids into animal cells |
| US5204253A (en) | 1990-05-29 | 1993-04-20 | E. I. Du Pont De Nemours And Company | Method and apparatus for introducing biological substances into living cells |
| US5972351A (en) * | 1992-04-03 | 1999-10-26 | Isis Innovation Limited | Plasmodium falciparum MHC class I-restricted CTL epitopes derived from pre-erythrocytic stage antigens |
| ES2139012T3 (es) * | 1992-05-26 | 2000-02-01 | Univ Leiden | Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana. |
| AU4528493A (en) | 1992-06-04 | 1994-01-04 | Regents Of The University Of California, The | In vivo gene therapy with intron-free sequence of interest |
| ATE342730T1 (de) * | 1992-08-07 | 2006-11-15 | Pharmexa Inc | Hla bindepeptide und ihre verwendungen |
| WO1994020127A1 (en) * | 1993-03-05 | 1994-09-15 | Cytel Corporation | Hla-a2.1 binding peptides and their uses |
| EP0735893B1 (en) | 1993-09-14 | 2008-11-26 | Pharmexa Inc. | Pan dr-binding peptides for enhancement of the immune response |
| US5686068A (en) * | 1994-03-24 | 1997-11-11 | Ludwig Institute For Cancer Research | Isolated peptides derived from MAGE-2, cytolytic T cells specific to complexes of peptide and HLA-A2 molecules, and uses thereof |
| US6071890A (en) | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| JPH10510988A (ja) * | 1994-12-14 | 1998-10-27 | ザ スクリップス リサーチ インスティテュート | 腫瘍−特異的細胞毒性ｔ細胞のインビボ活性化 |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| DK0900380T3 (da) * | 1996-04-26 | 2003-11-03 | Seed Capital Investments | Fremgangsmåde til udvælgelse og fremstilling af T-celle-peptid-epitoper og vacciner indeholdende disse udvalgte epitoper |
-
1999
- 1999-06-17 DE DE69940774T patent/DE69940774D1/de not_active Expired - Lifetime
- 1999-06-17 EP EP99928792A patent/EP1089757B1/en not_active Expired - Lifetime
- 1999-06-17 EP EP08018213A patent/EP2036573A1/en not_active Withdrawn
- 1999-06-17 CA CA002330824A patent/CA2330824A1/en not_active Abandoned
- 1999-06-17 ES ES99928792T patent/ES2326146T3/es not_active Expired - Lifetime
- 1999-06-17 WO PCT/US1999/013789 patent/WO1999065522A1/en not_active Ceased
- 1999-06-17 AU AU45778/99A patent/AU4577899A/en not_active Abandoned
- 1999-06-17 AT AT99928792T patent/ATE429247T1/de not_active IP Right Cessation
- 1999-06-17 JP JP2000554400A patent/JP2002518346A/ja active Pending
-
2010
- 2010-01-12 JP JP2010004446A patent/JP2010090167A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001521739A5 (enExample) | ||
| IL142905A0 (en) | Functional antagonists of hedgehog activity | |
| JP2004517472A5 (enExample) | ||
| EP1917970A3 (en) | Hla binding peptides and their uses | |
| JP2002527052A5 (enExample) | ||
| AU8762991A (en) | Human papilloma viral protein expression for use in vaccine compositions | |
| WO1999012968A3 (en) | Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response | |
| JPH1045637A5 (enExample) | ||
| EP1378245A3 (en) | Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis. Their use in a vaccine | |
| ATE183514T1 (de) | Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten | |
| HUP9900050A3 (en) | Recombinant adenoviruses, use thereof for preparing aavs, complementary cell line, and pharmaceutical compositions containing said recombinant adenoviruses | |
| FI940054A0 (fi) | Peptider av humant papillomavirus foer anvaendning i kompositioner som inducerar human T-cellsvar | |
| NO20101441L (no) | Tolerogent peptid og farmasoytisk preparat inneholdende det samme | |
| JP2002518346A5 (enExample) | ||
| JPH11302527A5 (enExample) | ||
| EP2213302A3 (en) | DR4 antibodies and uses thereof | |
| KR970704461A (ko) | Hla 결합 펩티드 및 그의 용도(hla binding peptides and their uses) | |
| IL139435A0 (en) | Antibodies to dendritic cells and human dendritic cell populations and uses thereof | |
| JP2001513504A5 (enExample) | ||
| AU6930200A (en) | Use of lentiviral vectors for antigen presentation in dendritic cells | |
| EP1944373A3 (en) | Method for purifying interleukin 1 receptor antagonist (IL-1ra) proteins | |
| AU6001100A (en) | Viral protein binding compositions and methods | |
| Bernstein et al. | People of the opiate. | |
| ATE191855T1 (de) | Depotzubereitung | |
| AU2002225533A1 (en) | Efficient expression of plasmodium apical membrane antigen 1 in yeast cells |